Compounds > antioquine
Page last updated: 2024-08-04 07:50:31

antioquine

Description

antioquine: structure given in first source; bisbenzylisoquinoline alkaloid isolated from Pseudoxandra sclerocarpa [MeSH]

Cross-References

ID SourceID
PubMed CID168012395
MeSH IDM0166087

Synonyms (2)

Synonym
antioquine
AKOS040746582

Research

Studies (3)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
caffeine
1
purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic		1993199331.0medium001000
papaverine
1
benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines		antispasmodic drug;
vasodilator agent		1998199826.0medium001000
potassium chloride
1
inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer1992199232.0medium001000
rolipram
1
pyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor		1993199331.0medium001000
apomorphine
1
aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug		1998199826.0medium001000
glaucine
1
aporphine alkaloid;
organic heterotetracyclic compound;
polyether;
tertiary amino compound		antibacterial agent;
antineoplastic agent;
antitussive;
muscle relaxant;
NF-kappaB inhibitor;
plant metabolite;
platelet aggregation inhibitor;
rat metabolite		1998199826.0medium001000
diltiazem
1
5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent		1992199232.0medium001000
oxytocin
1
heterodetic cyclic peptide;
peptide hormone		oxytocic;
vasodilator agent		1992199232.0medium001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Muscle Contraction0
2
1993199828.5high002000
Muscle Relaxation0
2
1992199331.5high002000

Dosage (1)

ArticleYear
Antioquine: a new bisbenzylisoquinoleine alkaloid with calcium antagonist activity.
Archives internationales de pharmacodynamie et de therapie, , Volume: 297